These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5840987)

  • 41. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 42. [Reciprocal supraventricular paroxysmal tachycardia in pregnancy. Apropos of a case].
    Baroffio R; Tisi G; Borsellino G; Minnici G
    Minerva Ginecol; 1996; 48(7-8):327-30. PubMed ID: 8966006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intravenous Ajmalin (Gilurytmal) therapy of paroxysmal disorders of the heart rhythm].
    Moeller HC
    Ther Ggw; 1966 Jul; 105(7):933-6. PubMed ID: 5923792
    [No Abstract]   [Full Text] [Related]  

  • 44. Grand rounds. Paroxysmal supraventricular tachycardia: mechanism, diagnosis and treatment.
    Reddy CP
    J Ky Med Assoc; 1981 Oct; 79(10):661-9. PubMed ID: 7299249
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of termination of reentrant atrioventricular nodal paroxysmal supraventricular tachycardia by intravenous verapamil--an intracardiac electrophysiologic study.
    Shankar SJ; Sethi KK; Khalilullah M
    Indian Heart J; 1983; 35(1):8-18. PubMed ID: 6852846
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
    Sung RJ; Waxman HL; Elser B; Juma Z
    Clin Invest Med; 1980; 3(1-2):41-7. PubMed ID: 7009003
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical studies on the therapeutic value of propranolol (Inderal) in diseases of the circulatory system].
    Szulc EJ
    Przegl Lek; 1967 Jul; 23(7):593-6. PubMed ID: 6062562
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
    Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
    Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
    [No Abstract]   [Full Text] [Related]  

  • 50. [Role of cordarone in the treatment of paroxysmal supraventricular tachyarrhythmia in pre-excitation syndrome].
    Bokarev IN; Fomina IG
    Klin Med (Mosk); 1994; 72(6):29-31. PubMed ID: 7898003
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of verapamil on supraventricular tachycardia--electrophysiological study].
    Ishinaga T; Komatsu C; Tokuhisa Y; Tateishi O; Teruya H; Sato Y; Yoshimura S
    Kokyu To Junkan; 1983 Dec; 31(12):1347-54. PubMed ID: 6676805
    [No Abstract]   [Full Text] [Related]  

  • 52. [Electrophysiologic study of paroxysmal ventricular tachycardia resistant to drug therapy in evaluating treatment with an antitachycardia pacemaker].
    Grujić M; Djordjević M; Nedeljković S; Bozinović Lj; Mrdja S; Stojanov P; Velimirović D; Kecman Lj; Stojanović G; Knezević S
    Srp Arh Celok Lek; 1984 Oct; 112(10):1071-8. PubMed ID: 6537656
    [No Abstract]   [Full Text] [Related]  

  • 53. [Paroxysmal tachycardia in the fetus].
    van der Meijden WI; van Enk A; van de Logt F
    Ned Tijdschr Geneeskd; 1980 Aug; 124(33):1364-9. PubMed ID: 7412915
    [No Abstract]   [Full Text] [Related]  

  • 54. [Adenosine].
    Tebbenjohanns J; Lüderitz B
    Internist (Berl); 1995 Mar; 36(3):296-9. PubMed ID: 7737824
    [No Abstract]   [Full Text] [Related]  

  • 55. [Paroxysmal atrial fibrillation: which patients need anti-arrhythmia drugs?. Interview by Dr. med. Ulrike Hennemann].
    Meinertz T
    Fortschr Med; 1996 Aug; 114(24):42-3. PubMed ID: 8974971
    [No Abstract]   [Full Text] [Related]  

  • 56. [Adenosine for suppression of paroxysmal supraventricular tachycardia in a newborn infant. First case in Mexico].
    Richheimer Wohlmuth R; Iturralde Torres P; Rijlaarsdam M; Capuano Rafael J
    Arch Inst Cardiol Mex; 1995; 65(2):149-52. PubMed ID: 7639609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [How is prevention of thrombosis in paroxysmal absolute tachyarrhythmia managed?].
    Hoppe UC
    Dtsch Med Wochenschr; 2002 Mar; 127(13):700. PubMed ID: 11928065
    [No Abstract]   [Full Text] [Related]  

  • 58. Bouveret's syndrome: new cause of double-arch-shadow sign in cholecystosonography.
    Sáez Garmendia F; Lopez Ruiz JA; Martinez Alvarez A; Pena Sarnago JM; Calonge Ratia JA; Munoz Dermit F
    Eur J Radiol; 1984 Aug; 4(3):216-8. PubMed ID: 6468416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric retention caused by gallstones (Bouveret's syndrome).
    Nielsen SM; Nielsen PT
    Acta Chir Scand; 1983; 149(2):207-8. PubMed ID: 6880558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Calcium gluconate cou quinine as an effective symptomatic treatment in a case of paroxysmal bouveret tachycardia].
    PABSTLEBEN CE
    Dia Med; 1946 Apr; 18():372. PubMed ID: 20985943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.